CAC Software vs Zio XT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by 4DMedical (Imbio CAC Software)
VS
by iRhythm Technologies, Inc.

AI Verdict

Tool A, Imbio's CAC Software, specializes in analyzing non-contrast chest CT scans to quantify coronary artery calcification for cardiovascular disease risk assessment. In contrast, Tool B, iRhythm's Zio XT ECG Monitoring System, offers continuous wearable ECG monitoring for up to 14 days to detect and diagnose cardiac arrhythmias. While both fall under Cardiology AI, they address different diagnostic needs and utilize distinct data modalities (CT imaging vs. ECG biosensor data).

Choose CAC Software if…

Choose CAC Software if you need to assess a patient's risk for coronary artery disease by quantifying calcification in their coronary arteries. This tool is ideal for leveraging existing non-contrast chest CT scans to provide automated Agatston scores, arterial age, and 3D visualizations, aiding in proactive cardiovascular risk stratification.

View CAC Software →

Choose Zio XT ECG Monitoring System if…

Choose Zio XT ECG Monitoring System if you require continuous, long-term ambulatory cardiac monitoring to detect and diagnose arrhythmias. This wearable, lead-free biosensor is perfect for patients needing up to 14 days of discreet monitoring, providing high compliance and AI-powered analysis for accurate arrhythmia detection.

View Zio XT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CAC Software Zio XT ECG Monitoring System
Pricing Unknown Contact for pricing
Deployment Cloud-based (SaaS), integrates with PACS Cloud-based (AWS EC2 platform), no on-premise hardware required.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio XT ECG Monitoring System

Tool B's Zio XT system prioritizes patient comfort and ease of use with its wearable, wire-free, and water-resistant biosensor, which is crucial for high patient compliance during long-term monitoring. While Tool A integrates well into existing clinical workflows, Tool B's patient-centric design offers a more significant advantage for its intended use.

Clinical Value

Tie

Both tools are FDA-cleared and provide substantial clinical value in different areas of cardiology. Tool A offers quantitative risk assessment for coronary artery disease from CT scans, while Tool B provides extended, accurate arrhythmia detection and diagnosis through continuous ECG monitoring. Their distinct applications make a direct comparison of overall clinical value challenging.

Pricing & Value

Zio XT ECG Monitoring System

Tool B demonstrates greater transparency in its pricing by providing specific cost examples for the UK and proposed US Medicare reimbursement rates, even while stating 'contact for pricing' for general inquiries. Tool A only provides 'contact for pricing,' offering no immediate insight into its cost structure or value proposition.

Enterprise Readiness

CAC Software

Tool A offers more versatile deployment options, including cloud, on-premise, and integration with partner platforms, which caters to a broader range of enterprise IT infrastructures and preferences. Tool B's cloud-only deployment, while robust, may not meet the requirements of all institutional environments.

Innovation

Zio XT ECG Monitoring System

Tool B exhibits greater innovation by combining a patient-friendly, long-term wearable biosensor with proprietary FDA-cleared deep-learned AI and expert review for continuous cardiac monitoring. This approach significantly advances the accessibility and delivery of arrhythmia diagnostics compared to Tool A's automation of existing CT image analysis.

Support & Docs

Zio XT ECG Monitoring System

Tool B provides readily accessible and comprehensive patient-centric documentation, including FAQs, Instructions for Use (IFUs), and Clinical Reference Manuals online, along with phone and email support. While Tool A also offers robust support channels and documentation, Tool B's transparent and easily available resources for both patients and clinicians give it a slight advantage for a device requiring patient interaction.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CAC Software Zio XT ECG Monitoring System
Name CAC Software Zio XT ECG Monitoring System
Company Imbio iRhythm Technologies
Primary Function Automated image post-processing for coronary artery calcification from non-contrast chest CT. Wearable, single-lead ECG biosensor for up to 14 days of continuous cardiac monitoring.
Input Data Type Non-contrast, chest computed tomography (CT) scans Single-lead ECG biosensor data
Key Outputs/Analysis Agatston score, arterial age, calcified lesion mass and volume, 3D visualizations, annotated images Arrhythmia detection and diagnosis, ECG data analysis, data storage and reporting
Categories Cardiology AI Cardiology AI, Wearables & Remote Monitoring (RPM)

Videos

Demos, reviews, and walkthroughs featuring CAC Software and Zio XT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio's CAC Software is designed to help radiologists and cardiologists quantify coronary artery calcification from non-contrast chest CT scans to support risk assessment for coronary artery disease. The Zio XT ECG Monitoring System by iRhythm Technologies provides continuous ambulatory cardiac monitoring for up to 14 days, utilizing AI and expert review for accurate arrhythmia detection and diagnosis.
Imbio's CAC Software analyzes existing non-contrast chest CT images to determine and quantify calcification within the coronary arteries. In contrast, the Zio XT ECG Monitoring System uses a wearable, single-lead ECG biosensor that continuously records cardiac activity for up to 14 days.
Imbio's CAC Software outputs the Agatston score, arterial age, calcified lesion mass and volume, along with 3D visualizations and annotated images. The Zio XT system provides a clinically actionable summary of recorded ECG data, including arrhythmia episodes, wear and analysis time, and patient-captured events, after analysis by its algorithm and review by certified cardiac physiologists.
Imbio's CAC Software is primarily intended for use by radiologists and cardiologists. The Zio XT ECG Monitoring System is designed for cardiologists, emergency medicine, and internal medicine specialists.
Imbio's CAC Software is designed to integrate into existing DICOM viewing workflows, PACS, and EMR systems, automatically processing images and returning results. The Zio XT service offers seamless EHR integration, allowing providers to order monitors and receive reports directly within their Epic environment via the Aura network, and also provides the ZioSuite portal for managing patients and interpreting reports.
Imbio's CAC Software is a non-invasive analysis of existing CT scans, with no direct patient interaction with the software itself. The Zio XT biosensor is a wearable, water-resistant patch that allows patients to continue normal daily activities, including showering, for up to 14 days, with no external leads or wires for enhanced comfort and high patient compliance.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.